TipRanks on MSN6d
AIM Vaccine Secures Approval for Advanced Rabies Vaccine, Bolstering Global Market PositionAn update from AIM Vaccine Co., Ltd. Class H ( ($HK:6660) ) is now available. AIM Vaccine Co., Ltd. has received approval from the National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback